[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
Global Mutation Detection Kits In Genome Editing Market
Pharmaceuticals

Mutation Detection Kits In Genome Editing Market Size and Growth Forecast for Businesses 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Mutation Detection Kits In Genome Editing Market Size During 2025–2029?

The segment for mutation detection kits within the genome editing market has experienced substantial growth in recent years. It is projected to expand from $1.01 billion in 2024 to $1.14 billion in 2025, showing a compound annual growth rate (CAGR) of 13.4%. This historical growth can be attributed to several factors, including heightened research into genetic disorders, increased government funding allocated to genomics, a rise in academic and clinical research collaborations, the growing availability of sophisticated molecular biology tools, and increased investments from biotechnology companies.

The mutation detection kits segment within the genome editing market is anticipated to experience substantial growth over the coming years. It is projected to reach $1.86 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 13.1%. This expansion during the forecast period can be attributed to the rising adoption of autonomous mobile robots (AMRs), an increased focus on supply chain visibility, growing investment in digital twin technologies, an increasing demand for real-time asset tracking, and the wider uptake of industrial automation. Significant trends expected during this period include advancements in real-time location systems (RTLS), innovations in AI-powered asset tracking, the integration of RFID with IoT platforms, progress in ultra-wideband (UWB) technology, and the incorporation of digital twin solutions for industrial automation.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27356&type=smp

What Are The Top Growth Drivers Impacting The Mutation Detection Kits In Genome Editing Market Outlook?

The increasing incidence of genetic conditions is anticipated to fuel the expansion of mutation detection kits within the genome editing market moving ahead. Genetic disorders are defined as illnesses or states arising from irregularities in a person’s DNA, potentially passed down from parents or emerging from novel genetic changes. The growth in genetic disorders stems from heightened public understanding and sophisticated diagnostic tools, facilitating quicker and more precise recognition of these conditions, leading to elevated reported rates of occurrence. Mutation detection kits used in genome editing contribute to tackling genetic disorders by precisely locating gene mutations responsible for diseases, thereby facilitating focused research and the creation of accurate therapeutic solutions. As an illustration, in May 2024, data from the National Health Service, a UK government department, indicated that in England, roughly 17,000 individuals suffer from sickle cell disease, an inherited blood condition, with about 250 new diagnoses occurring annually. Consequently, the growing frequency of genetic disorders is stimulating the demand for mutation detection kits in the genome editing market.

What Are The Emerging Segments Gaining Attention In The Mutation Detection Kits In Genome Editing Market?

The mutation detection kits in genome editing market covered in this report is segmented

1) By Product Type: Reagents, Kits, Software Solutions

2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nucleases Or Meganuclease-TAL Effector Nucleases (TALENs/MegaTALs), Zinc Finger Nucleases (ZFN), Other Technologies

3) By Application: Research, Clinical Diagnostics, Drug Development, Other Applications

4) By End Use: Academic Institutions, Hospitals And Diagnostic Centers, Biotechnology Companies

Subsegments:

1) By Reagents: Deoxyribonucleic Acid Polymerases (DNA) Polymerases, Nucleases, Buffers And Enzymes, Fluorescent Dyes And Probes, Primers And Oligonucleotides

2) By Kits: Polymerase Chain Reaction (PCR)-Based Mutation Detection Kits, Next-Generation Sequencing-Based Mutation Analysis Kits, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Mutation Validation Kits, Gel Electrophoresis-Based Detection Kits

3) By Software Solutions: Mutation Analysis And Visualization Tools, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Off-Target Prediction Software, Genomic Alignment and Annotation Software, Data Interpretation Platforms For Next-Generation Sequencing, Cloud-Based Bioinformatics Platforms

Which Ongoing Trends Are Expected To Shape The Mutation Detection Kits In Genome Editing Market Outlook?

Key companies engaged in the mutation detection kits in the genome editing market are prioritizing the development of advanced solutions, such as ultrasensitive multiplexed assays, to improve the accuracy, speed, and sensitivity of identifying genetic mutations. Ultrasensitive multiplexed assays are sophisticated diagnostic tests designed to detect and quantify multiple genetic mutations simultaneously at very low levels, helping researchers and clinicians achieve faster, more precise, and comprehensive mutation analysis for enhanced disease diagnosis and treatment monitoring. For example, in April 2024, Bio-Rad Laboratories Inc., a US-based research company, launched the ddPLEX ESR1 Mutation Detection Kit, an ultrasensitive multiplexed digital PCR assay developed for breast cancer mutation detection. This kit allows for the simultaneous identification and accurate quantification of seven ESR1 mutations, offering an analytical sensitivity down to 0.01% variant allele fraction, and supports analysis of both plasma and tissue samples. These types of innovations demonstrate the industry’s commitment to enhancing diagnostic accuracy and enabling more effective disease monitoring and personalized treatment strategies.

Who Are The Prominent Global Companies Shaping The Mutation Detection Kits In Genome Editing Market?

Major companies operating in the mutation detection kits in genome editing market are F. Hoffmann-La Roche Ltd, Merck KGaA, Thermo Fisher Scientific Inc., QIAGEN N.V., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Analytik Jena AG, Twist Bioscience Corporation, New England Biolabs Inc., Applied Biological Materials Inc., Synthego Corporation, Cell Signaling Technology Inc., BioVision Inc., Creative Biogene Corporation.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/mutation-detection-kits-in-genome-editing-global-market-report

Which Region Currently Holds The Largest Share Of The Mutation Detection Kits In Genome Editing Market?

North America was the largest region in the mutation detection kits in genome editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mutation detection kits in genome editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Mutation Detection Kits In Genome Editing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27356&type=smp

Browse Through More Reports Similar to the Global Mutation Detection Kits In Genome Editing Market 2025, By The Business Research Company

Pet Insurance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pet-insurance-global-market-report

Pet Healthcare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pet-healthcare-global-market-report

Accidental Death Insurance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/accidental-death-insurance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong. [KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.